Follow
Ian Galea
Title
Cited by
Cited by
Year
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both …
SR Irani, K Bera, P Waters, L Zuliani, S Maxwell, MS Zandi, MA Friese, ...
Brain 133 (6), 1655-1667, 2010
10342010
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ...
The Lancet Psychiatry 7 (10), 875-882, 2020
10292020
What is immune privilege (not)?
I Galea, I Bechmann, VH Perry
Trends in immunology 28 (1), 12-18, 2007
8552007
The blood-brain barrier in systemic inflammation
A Varatharaj, I Galea
Brain, behavior, and immunity 60, 1-12, 2017
6512017
What is the blood–brain barrier (not)?
I Bechmann, I Galea, VH Perry
Trends in immunology 28 (1), 5-11, 2007
6182007
CD163‐positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation
BO Fabriek, ES Van Haastert, I Galea, MMJ Polfliet, ED Döpp, ...
Glia 51 (4), 297-305, 2005
2282005
An antigen-specific pathway for CD8 T cells across the blood-brain barrier
I Galea, M Bernardes-Silva, PA Forse, N van Rooijen, RS Liblau, ...
The Journal of experimental medicine 204 (9), 2023-2030, 2007
2122007
Tumor necrosis factor α‐converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163
A Etzerodt, MB Maniecki, K Møller, HJ Møller, SK Moestrup
Journal of leukocyte biology 88 (6), 1201-1205, 2010
2032010
Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain
I Galea, K Palin, TA Newman, N Van Rooijen, VH Perry, D Boche
Glia 49 (3), 375-384, 2005
1782005
Pathophysiology of the lymphatic drainage of the central nervous system: Implications for pathogenesis and therapy of multiple sclerosis
RO Weller, I Galea, RO Carare, A Minagar
Pathophysiology 17 (4), 295-306, 2010
1442010
Natalizumab for relapsing remitting multiple sclerosis
E Pucci, G Giuliani, A Solari, S Simi, S Minozzi, C Di Pietrantonj, I Galea
Cochrane Database of Systematic Reviews, 2011
1282011
Corticosteroids for the long‐term treatment in multiple sclerosis
A Ciccone, S Beretta, F Brusaferri, I Galea, A Protti, C Spreafico
Cochrane Database of Systematic Reviews, 2008
1112008
Outcome and biomarker analysis from a multicenter phase 2 study of ipilimumab in combination with carboplatin and etoposide as first-line therapy for extensive-stage SCLC
E Arriola, M Wheater, I Galea, N Cross, T Maishman, D Hamid, L Stanton, ...
Journal of Thoracic Oncology 11 (9), 1511-1521, 2016
1032016
The intrathecal CD163‐haptoglobin–hemoglobin scavenging system in subarachnoid hemorrhage
J Galea, G Cruickshank, JL Teeling, D Boche, P Garland, VH Perry, ...
Journal of neurochemistry 121 (5), 785-792, 2012
992012
Cognitive and behavioural correlates of different domains of psychological adjustment in early-stage multiple sclerosis
L Dennison, R Moss-Morris, E Silber, I Galea, T Chalder
Journal of psychosomatic research 69 (4), 353-361, 2010
842010
The effect of systemic inflammation on human brain barrier function
E Elwood, Z Lim, H Naveed, I Galea
Brain, behavior, and immunity 62, 35-40, 2017
802017
Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages
A Etzerodt, MR Rasmussen, P Svendsen, A Chalaris, J Schwarz, I Galea, ...
Journal of Biological Chemistry 289 (2), 778-788, 2014
722014
Haemoglobin scavenging in intracranial bleeding: biology and clinical implications
D Bulters, B Gaastra, A Zolnourian, S Alexander, D Ren, SL Blackburn, ...
Nature Reviews Neurology 14 (7), 416-432, 2018
682018
Relapse in multiple sclerosis
I Galea, N Ward-Abel, C Heesen
Bmj 350, 2015
662015
How do people with multiple sclerosis experience prognostic uncertainty and prognosis communication? A qualitative study
L Dennison, E McCloy Smith, K Bradbury, I Galea
PloS one 11 (7), e0158982, 2016
572016
The system can't perform the operation now. Try again later.
Articles 1–20